We thought you might like to know that over the last year alone, Northbank has
successfully delivered communications programmes that have helped our life sciences clients raise over €275 million in private equity financings,
over €550 million in partnering deals and facilitated two major acquisitions by blue chip
pharma companies.
Venture Financing
€40m
Series C Financing
€22m
Series A Financing
€42m
Series B Financing
Corp & Fin
Comms Worldwide
Corp & Fin
Comms Worldwide
Media Relations
Across Europe
€30m
Series B Financing
€22m
Series C Financing
€20m
Series B Financing
Media Relations
Across Europe
Corp & Fin
Comms Worldwide
Corp Comms
Worldwide
€25m
Series B Financing
€15m
Series A Financing
£20m
Series B Financing
Corp & Fin Comms
Worldwide
Corp, Fin & Commercial PR
Worldwide
Corp & Fin Comms
Worldwide
Deals
$265m Deal with
Boehringer Ingelheim
$213m Deal
with Wyeth
Acquisition by
GE Healthcare
Corp & Fin
Comms Worldwide
Corp & Fin
Comms Worldwide
Marketing
Comms Worldwide
$190m Deal with
Genentech
Spin-out from ABN AMRO CLS
$690m Deal with
Sanofi-Aventis
Corp Comms
Worldwide
Media Relations
Worldwide
Corp Image & Commercial PR
Worldwide
Acquisition by
Pfizer
Joint License Deal
with GSK
Acquisition by
Illumina
Corp, Fin & Healthcare Comms
Prior to Pfizer Acquisition
Marketing Comms
Worldwide
Marketing Comms
Worldwide
If you would like further information on how Northbank can help you, or your portfolio companies, achieve similar success please contact: